References
Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659–2668
Lodi R, Parchi P, Tonon C, Manners D, Capellari S, Strammiello R, Rinaldi R, Testa C, Malucelli E, Mostacci B, Rizzo G, Pierangeli G, Cortelli P, Montagna P, Barbiroli B (2009) Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 132:2669–2679
Galanaud D, Haik S, Linguraru MG, Ranjeva JP, Faucheux B, Kaphan E, Ayache N, Chiras J, Cozzone P, Dormont D, Brandel JP (2010) Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases. Am J Neuroradiol 31:1311–1318
Soares DP, Law M (2009) Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 64:12–21
World Health Organization (1998) Human transmissible spongiform encephalopathies. WHO Weekly Epidemiological Record 73:361–372
Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, Prohovnik I (2006) The imaging appearance of Creutzfeldt-Jakob disease caused by the E200 K mutation. Magn Reson Imaging 24:1121–1129
Waldman AD, Cordery RJ, MacManus DG, Godbolt A, Collinge J, Rossor MN (2006) Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy. Neuroradiology 48:428–433
Haïk S, Galanaud D, Linguraru MG, Peoc’h K, Privat N, Faucheux BA, Ayache N, Hauw JJ, Dormont D, Brandel JP (2008) In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. Arch Neurol 65:545–549
Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625–10629
Kleene R, Loers G, Langer J, Frobert Y, Buck F, Schachner M (2007) Prion protein regulates glutamate-dependent lactate transport of astrocyte. J Neurosci 27:12331–12340
Awerbuch G, Peterson P, Sandyk R (1988) Elevated cerebrospinal fluid lactic acid levels in Creutzfeldt-Jakob disease. Int J Neurosci 42:1–5
Kitamoto T, Muramoto T, Hilbich C, Beyreuther K, Tateishi J (1991) N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome. Brain Res 545:319–321
Acknowledgments
We thank Tetsuyuki Kitamoto (Tohoku University, analyses of PRNP and pathology); Shuji Hashiguchi and Katsuhito Adachi (Tokushima Hospital, clinical care and the necropsy procedure); Katsuya Satoh (Nagasaki University, measurement of 14-3-3 protein); and Toshiaki Sano (The University of Tokushima, necropsy procedure). This work was supported by Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labour and Welfare of Japan.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujita, K., Harada, M., Yuasa, T. et al. Temporal evolution of sporadic Creutzfeldt–Jakob disease monitored by 3-Tesla MR spectroscopy. J Neurol 258, 1368–1370 (2011). https://doi.org/10.1007/s00415-011-5939-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-5939-7